Saudou
Frederic Saudou, Orsay FR
Patent application number | Description | Published |
---|---|---|
20080300178 | Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421 - The present invention relates to a method for treating patients having Huntington's disease by a drug increasing the phosphorylation of huntingtin at position S421, thereby decreasing the polyQ-huntingtin-induced toxicity. | 12-04-2008 |
20110039789 | Use of Huntingtin Protein for the Diagnosis and the Treatment of Cancer - The present invention relates to new methods of treatment of cancer, in particular of breast cancer, and methods of screening of compounds useful in the treatment of cancer. The present invention further provides new prognostic and/or diagnostic markers in human cancer. | 02-17-2011 |
20130316961 | TREATMENT OF MECP-2 ASSOCIATED DISORDERS - The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome. | 11-28-2013 |
Frédéric Saudou, Orsay FR
Patent application number | Description | Published |
---|---|---|
20130316961 | TREATMENT OF MECP-2 ASSOCIATED DISORDERS - The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome. | 11-28-2013 |
Frédérie Saudou, Orsay FR
Patent application number | Description | Published |
---|---|---|
20150265554 | Treatment of MeCP-2 Associated Disorders - The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome. | 09-24-2015 |